Genetic resistance determinants, in vitro time-kill curve analysis and pharmacodynamic functions for the novel topoisomerase II inhibitor ETX0914 (AZD0914) in Neisseria gonorrhoeae
Resistance in Neisseria gonorrhoeae to all available therapeutic antimicrobials has emerged and new efficacious drugs for treatment of gonorrhea are essential. The topoisomerase II inhibitor ETX0914 (also known as AZD0914) is a new spiropyrimidinetrione antimicrobial that has different mechanisms of...
Main Authors: | Sunniva eFoerster, Daniel eGolparian, Susanne eJacobsson, Lucy eHathaway, Nicola eLow, William eShafer, Christian eAlthaus, Magnus eUnemo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-12-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fmicb.2015.01377/full |
Similar Items
-
Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005–2019
by: Ricardo Ariel Gianecini, et al.
Published: (2021-09-01) -
The immunoproteasome‐specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis
by: Nadine Althof, et al.
Published: (2018-02-01) -
Short-Term ONX-0914 Administration: Performance and Muscle Phenotype in <i>Mdx</i> Mice
by: Dongmin Kwak, et al.
Published: (2020-07-01) -
Immunoproteasome Activity and Content Determine Hematopoietic Cell Sensitivity to ONX-0914 and to the Infection of Cells with Lentiviruses
by: Elmira Vagapova, et al.
Published: (2021-05-01) -
Emergence and Spread of Cephalosporin-Resistant Neisseria gonorrhoeae with Mosaic penA Alleles, South Korea, 2012–2017
by: Hyukmin Lee, et al.
Published: (2019-03-01)